Ly6

Ly6 also known as lymphocyte antigen 6 or urokinase-type plasminogen activator receptor (uPAR) is family of proteins that share a common structure but differ in their tissue expression patterns and function. Ly6 are cysteine-rich proteins that form disulfide bridges and contain a LU domain. These proteins are GPI-anchored to the cell membrane or are secreted. A total of 35 human and 61 mouse Ly6 family members have been identified.[1] Depending on which tissues they are expressed in, LY6 family members have different roles. They are expressed in various types of tissues and their expression dependent on the stage of cell differentiation.[1][2] For example, they are involved in cell proliferation, cell migration, cell–cell interactions, immune cell maturation, macrophage activation, and cytokine production.[3][1] Their overexpression or dysregulation, for example due to point mutations, is associated with tumorogenesis and autoimmune diseases.[4][5] This family was discovered in the 1970s,[6] and these proteins are still used as markers of distinct stage of leukocyte differentiation.[3]

  1. ^ a b c Loughner CL, Bruford EA, McAndrews MS, Delp EE, Swamynathan S, Swamynathan SK (April 2016). "Organization, evolution and functions of the human and mouse Ly6/uPAR family genes". Human Genomics. 10 (1): 10. doi:10.1186/s40246-016-0074-2. PMC 4839075. PMID 27098205.
  2. ^ Lee PY, Wang JX, Parisini E, Dascher CC, Nigrovic PA (October 2013). "Ly6 family proteins in neutrophil biology". Journal of Leukocyte Biology. 94 (4): 585–94. doi:10.1189/jlb.0113014. PMID 23543767. S2CID 1252351.
  3. ^ a b Kong HK, Park JH (November 2012). "Characterization and function of human Ly-6/uPAR molecules". BMB Reports. 45 (11): 595–603. doi:10.5483/bmbrep.2012.45.11.210. PMC 4133805. PMID 23186997.
  4. ^ Upadhyay G (2019). "Emerging Role of Lymphocyte Antigen-6 Family of Genes in Cancer and Immune Cells". Frontiers in Immunology. 10: 819. doi:10.3389/fimmu.2019.00819. PMC 6491625. PMID 31068932.
  5. ^ Sidenius N, Blasi F (June 2003). "The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy". Cancer and Metastasis Reviews. 22 (2–3): 205–22. doi:10.1023/A:1023099415940. PMID 12784997. S2CID 5765336.
  6. ^ McKenzie IF, Gardiner J, Cherry M, Snell GD (March 1977). "Lymphocyte antigens: Ly-4, Ly-6, and Ly-7". Transplantation Proceedings. 9 (1): 667–9. PMID 68598.